C103H126N24O12S — CID 159384789
(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-4-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-cyclohexylbutanoyl]-N-methyl-N-(1-methylpyrazol-3-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-1-[(3S)-3-(1-methylpyrazol-3-yl)pentanoyl]-4-oxo-N-thiophen-2-ylazetidine-2-carboxamide (PubChem CID 159384789) has the molecular formula C103H126N24O12S and a molecular weight of 1924.36 g/mol. Its IUPAC name is (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-4-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-cyclohexylbutanoyl]-N-methyl-N-(1-methylpyrazol-3-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-1-[(3S)-3-(1-methylpyrazol-3-yl)pentanoyl]-4-oxo-N-thiophen-2-ylazetidine-2-carboxamide.
| Compound Name | (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-4-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-cyclohexylbutanoyl]-N-methyl-N-(1-methylpyrazol-3-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-1-[(3S)-3-(1-methylpyrazol-3-yl)pentanoyl]-4-oxo-N-thiophen-2-ylazetidine-2-carboxamide |
|---|---|
| PubChem CID | 159384789 |
| Molecular Formula | C103H126N24O12S |
| Molecular Weight | 1924.36 g/mol |
| Exact Mass | 1922.97 |
| IUPAC Name | (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-2-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-N-methyl-N-(1-methylimidazol-4-yl)-4-oxo-1-[(3S)-3-phenylpentanoyl]azetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-1-[(3S)-3-cyclohexylbutanoyl]-N-methyl-N-(1-methylpyrazol-3-yl)-4-oxoazetidine-2-carboxamide;(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-N-methyl-1-[(3S)-3-(1-methylpyrazol-3-yl)pentanoyl]-4-oxo-N-thiophen-2-ylazetidine-2-carboxamide |
| SMILES | CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1cn(C)cn1)c1ccccc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1nccn1C)c1ccccc1.CC[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1cccs1)c1ccn(C)n1.C[C@@H](CC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1ccn(C)n1)C1CCCCC1 |
| InChI | InChI=1S/2C27H32N6O3.C25H34N6O3.C24H28N6O3S/c1-5-19(20-9-7-6-8-10-20)14-24(34)33-25(27(36)32(4)23-15-31(3)16-29-23)21(26(33)35)12-18-11-17(2)30-22(28)13-18;1-5-19(20-9-7-6-8-10-20)16-23(34)33-24(26(36)32(4)27-29-11-12-31(27)3)21(25(33)35)14-18-13-17(2)30-22(28)15-18;1-16(18-7-5-4-6-8-18)13-22(32)31-23(25(34)30(3)21-10-12-29(2)28-21)19(24(31)33)14-17-9-11-27-20(26)15-17;1-4-16(18-8-10-28(2)27-18)14-20(31)30-22(24(33)29(3)21-6-5-11-34-21)17(23(30)32)12-15-7-9-26-19(25)13-15/h6-11,13,15-16,19,21,25H,5,12,14H2,1-4H3,(H2,28,30);6-13,15,19,21,24H,5,14,16H2,1-4H3,(H2,28,30);9-12,15-16,18-19,23H,4-8,13-14H2,1-3H3,(H2,26,27);5-11,13,16-17,22H,4,12,14H2,1-3H3,(H2,25,26)/t19-,21+,25-;19-,21+,24-;16-,19+,23-;16-,17+,22-/m0000/s1 |
| InChIKey | LLIZLZPWDYZCRO-ITMKXBLDSA-N |
| XLogP | 10.86 |
| TPSA | 457.68 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 140 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1924.36 |
| LogP ≤ 5 | 10.86 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 29 |